BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 29185073)

  • 1. Computational systems biology approaches for Parkinson's disease.
    Glaab E
    Cell Tissue Res; 2018 Jul; 373(1):91-109. PubMed ID: 29185073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing Alzheimer's and Parkinson's diseases networks using graph communities structure.
    Calderone A; Formenti M; Aprea F; Papa M; Alberghina L; Colangelo AM; Bertolazzi P
    BMC Syst Biol; 2016 Mar; 10():25. PubMed ID: 26935435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systems biology approach towards the identification of candidate therapeutic genes and potential biomarkers for Parkinson's disease.
    Sakharkar MK; Kashmir Singh SK; Rajamanickam K; Mohamed Essa M; Yang J; Chidambaram SB
    PLoS One; 2019; 14(9):e0220995. PubMed ID: 31487305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative system biology strategies for disease biomarker discovery.
    Zhang H; Hu H; Deng C; Chun Y; Zhou S; Huang F; Zhou Q
    Comb Chem High Throughput Screen; 2012 May; 15(4):286-98. PubMed ID: 22221061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in protein-protein interaction network analysis for Parkinson's disease.
    Tomkins JE; Manzoni C
    Neurobiol Dis; 2021 Jul; 155():105395. PubMed ID: 34022367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction: Cancer Gene Networks.
    Clarke R
    Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal Fluid Metabolome in Parkinson's Disease and Multiple System Atrophy.
    Kwon DH; Hwang JS; Kim SG; Jang YE; Shin TH; Lee G
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
    Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
    BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach.
    Edwards YJ; Beecham GW; Scott WK; Khuri S; Bademci G; Tekin D; Martin ER; Jiang Z; Mash DC; ffrench-Mullen J; Pericak-Vance MA; Tsinoremas N; Vance JM
    PLoS One; 2011 Feb; 6(2):e16917. PubMed ID: 21364952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative transcriptome analysis of Parkinson's disease and Hutchinson-Gilford progeria syndrome reveals shared susceptible cellular network processes.
    Hendrickx DM; Glaab E
    BMC Med Genomics; 2020 Aug; 13(1):114. PubMed ID: 32811487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
    George G; Valiya Parambath S; Lokappa SB; Varkey J
    Gene; 2019 May; 697():67-77. PubMed ID: 30776463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pathway and network analysis of brain transcriptome changes during adult aging and in Parkinson's disease.
    Glaab E; Schneider R
    Neurobiol Dis; 2015 Feb; 74():1-13. PubMed ID: 25447234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson's disease.
    Chen X; Cao W; Zhuang Y; Chen S; Li X
    Brain Res Bull; 2021 Dec; 177():53-63. PubMed ID: 34536521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hallmarks of Parkinson's disease.
    Antony PM; Diederich NJ; Krüger R; Balling R
    FEBS J; 2013 Dec; 280(23):5981-93. PubMed ID: 23663200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials.
    Castrillo JI; Lista S; Hampel H; Ritchie CW
    Methods Mol Biol; 2018; 1750():31-66. PubMed ID: 29512064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying the hub gene and immune infiltration of Parkinson's disease using bioinformatical methods.
    Liu SH; Wang YL; Jiang SM; Wan XJ; Yan JH; Liu CF
    Brain Res; 2022 Jun; 1785():147879. PubMed ID: 35278479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copy number variability in Parkinson's disease: assembling the puzzle through a systems biology approach.
    La Cognata V; Morello G; D'Agata V; Cavallaro S
    Hum Genet; 2017 Jan; 136(1):13-37. PubMed ID: 27896429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics-based tools in drug discovery: the cartography from single gene to integrative biological networks.
    Ramharack P; Soliman MES
    Drug Discov Today; 2018 Sep; 23(9):1658-1665. PubMed ID: 29864527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network-based methods for identifying critical pathways of complex diseases: a survey.
    Zhang Q; Li J; Xue H; Kong L; Wang Y
    Mol Biosyst; 2016 Apr; 12(4):1082-9. PubMed ID: 26888073
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.